MiR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis

Immunity

Volumn 38, Issue 6, 2013, Pages 1236-1249

  Sonda, Nada ^a,b   Simonato, Francesca ^a   Peranzoni, Elisa ^b   Calì, Bianca ^a   Bortoluzzi, Stefania ^a   Bisognin, Andrea ^a   Wang, Ena ^d   Marincola, FrancescoM ^d,e   Naldini, Luigi ^f,g   Gentner, Bernhard ^f,g   Trautwein, Christian ^h   Sackett, SaraDutton ^h   Zanovello, Paola ^a,b   Molon, Barbara ^b,c   Bronte, Vincenzo ⁱ  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^f SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^g VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^h UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

ⁱ UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CD11B ANTIGEN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 142 3P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; MYELOPOIESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN; SURVIVAL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, NEOPLASM; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOKINE RECEPTOR GP130; IMMUNOTHERAPY; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; MYELOPOIESIS; NEOPLASMS, EXPERIMENTAL; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROID ISOMERASES; T-LYMPHOCYTES; TRANSGENES; TUMOR ESCAPE;

EID: 84879569764     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.06.004     Document Type: Article

References (57)

1. Baldwin B.R., Timchenko N.A., Zahnow C.A. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol. Cell. Biol. 2004, 24:3682-3691.
2. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008, 9:839-845.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Bayne L.J., Beatty G.L., Jhala N., Clark C.E., Rhim A.D., Stanger B.Z., Vonderheide R.H. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and Tcell immunity in pancreatic cancer. Cancer Cell 2012, 21:822-835.
5. Bronte V., Chappell D.B., Apolloni E., Cabrelle A., Wang M., Hwu P., Restifo N.P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ Tcell responses by dysregulating antigen-presenting cell maturation. J.Immunol. 1999, 162:5728-5737.
6. Chen C.Z., Lodish H.F. MicroRNAs as regulators of mammalian hematopoiesis. Semin. Immunol. 2005, 17:155-165.
7. Chen, C.Z., Li, L., Lodish, H.F., and Bartel, D.P. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, N.Y 303, 83-86.
8. Chen A., Luo M., Yuan G., Yu J., Deng T., Zhang L., Zhou Y., Mitchelson K., Cheng J. Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol. Lett. 2008, 30:2045-2052.
9. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 2000, 1:510-514.
10. Clark C.E., Hingorani S.R., Mick R., Combs C., Tuveson D.A., Vonderheide R.H. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007, 67:9518-9527.
11. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., Padhya T., McCaffrey T.V., McCaffrey J.C., Gabrilovich D.I. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J.Immunol. 2009, 182:5693-5701.
12. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., Geilich M., Winkels G., Traggiai E., Casati A., et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010, 40:22-35.
13. Duluc D., Delneste Y., Tan F., Moles M.P., Grimaud L., Lenoir J., Preisser L., Anegon I., Catala L., Ifrah N., et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007, 110:4319-4330.
14. 2 catabolism in myeloid cells. J.Leukoc. Biol. 2010, 88:839-848.
15. Fang Z., Rajewsky N. The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS ONE 2011, 6:e18067.
16. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C.M., Brunetti E., Grignani F., Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007, 9:775-787.
17. Fukuda A., Wang S.C., Morris J.P., Folias A.E., Liou A., Kim G.E., Akira S., Boucher K.M., Firpo M.A., Mulvihill S.J., Hebrok M. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 2011, 19:441-455.
18. Gabrilovich D.I., Ostrand-Rosenberg S., Bronte V. Coordinated regulation of myeloid cells by tumours. Nature reviews 2012, 12:253-268.
19. Gade P., Roy S.K., Li H., Nallar S.C., Kalvakolanu D.V. Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol. Cell. Biol. 2008, 28:2528-2548.
20. Gallina G., Dolcetti L., Serafini P., De Santo C., Marigo I., Colombo M.P., Basso G., Brombacher F., Borrello I., Zanovello P., et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ Tcells. J.Clin. Invest. 2006, 116:2777-2790.
21. Gil-Bernabé A.M., Ferjancic S., Tlalka M., Zhao L., Allen P.D., Im J.H., Watson K., Hill S.A., Amirkhosravi A., Francis J.L., et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 2012, 119:3164-3175.
22. Gutsch R., Kandemir J.D., Pietsch D., Cappello C., Meyer J., Simanowski K., Huber R., Brand K. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology. J.Biol. Chem. 2011, 286:22716-22729.
23. Hatfield S.D., Shcherbata H.R., Fischer K.A., Nakahara K., Carthew R.W., Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature 2005, 435:974-978.
24. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
25. Kusmartsev S., Gabrilovich D.I. STAT1 signaling regulates tumor-associated macrophage-mediated Tcell deletion. J.Immunol. 2005, 174:4880-4891.
26. Lawrence T., Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature reviews 2011, 11:750-761.
27. Lesina M., Kurkowski M.U., Ludes K., Rose-John S., Treiber M., Klöppel G., Yoshimura A., Reindl W., Sipos B., Akira S., et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 2011, 19:456-469.
28. + myeloid-derived suppressor cells from bone marrow cells. Int. J. Cancer 2011, 129:2662-2673.
29. Liu Y., Lai L., Chen Q., Song Y., Xu S., Ma F., Wang X., Wang J., Yu H., Cao X., Wang Q. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J.Immunol. 2012, 188:5500-5510.
30. Luedde T., Duderstadt M., Streetz K.L., Tacke F., Kubicka S., Manns M.P., Trautwein C. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 2004, 40:356-365.
31. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
32. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
33. Martinez-Nunez R.T., Louafi F., Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J.Biol. Chem. 2011, 286:1786-1794.
34. Miska E.A. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 2005, 15:563-568.
35. Montini E., Cesana D., Schmidt M., Sanvito F., Ponzoni M., Bartholomae C., Sergi Sergi L., Benedicenti F., Ambrosi A., Di Serio C., et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol. 2006, 24:687-696.
36. Movahedi K., Laoui D., Gysemans C., Baeten M., Stangé G., Van den Bossche J., Mack M., Pipeleers D., In't Veld P., De Baetselier P., VanGinderachter J.A. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010, 70:5728-5739.
37. Munera V., Popovic P.J., Bryk J., Pribis J., Caba D., Matta B.M., Zenati M., Ochoa J.B. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 2010, 251:120-126.
38. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nature reviews 2011, 11:723-737.
39. Nefedova Y., Nagaraj S., Rosenbauer A., Muro-Cacho C., Sebti S.M., Gabrilovich D.I. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 2005, 65:9525-9535.
40. Ostrand-Rosenberg S., Sinha P., Beury D.W., Clements V.K. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin. Cancer Biol. 2012, 22:275-281.
41. Pylayeva-Gupta Y., Lee K.E., Hajdu C.H., Miller G., Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012, 21:836-847.
42. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
43. Schmeier S., MacPherson C.R., Essack M., Kaur M., Schaefer U., Suzuki H., Hayashizaki Y., Bajic V.B. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics 2009, 10:595.
44. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J.Clin. Invest. 2007, 117:1155-1166.
45. Sica A., Mantovani A. Macrophage plasticity and polarization: invivo veritas. J.Clin. Invest. 2012, 122:787-795.
46. Smink J.J., Bégay V., Schoenmaker T., Sterneck E., de Vries T.J., Leutz A. Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO J. 2009, 28:1769-1781.
47. Sonda N., Chioda M., Zilio S., Simonato F., Bronte V. Transcription factors in myeloid-derived suppressor cell recruitment and function. Curr. Opin. Immunol. 2011, 23:279-285.
48. Takahashi H., Kanno T., Nakayamada S., Hirahara K., Sciumè G., Muljo S.A., Kuchen S., Casellas R., Wei L., Kanno Y., O'Shea J.J. TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper Tcells. Nat. Immunol. 2012, 13:587-595.
49. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
50. Torroella-Kouri M., Silvera R., Rodriguez D., Caso R., Shatry A., Opiela S., Ilkovitch D., Schwendener R.A., Iragavarapu-Charyulu V., Cardentey Y., et al. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 2009, 69:4800-4809.
51. Turner M.L., Schnorfeil F.M., Brocker T. MicroRNAs regulate dendritic cell differentiation and function. J.Immunol. 2011, 187:3911-3917.
52. Ugel S., Scarselli E., Iezzi M., Mennuni C., Pannellini T., Calvaruso F., Cipriani B., De Palma R., Ricci-Vitiani L., Peranzoni E., et al. Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. Blood 2010, 115:1374-1384.
53. Viola A., Sarukhan A., Bronte V., Molon B. Mol. Biol. Rep. 2012, 39:2713-2722.
54. Wang J., Liu Y., Li Z., Du J., Ryu M.J., Taylor P.R., Fleming M.D., Young K.H., Pitot H., Zhang J. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood 2010, 116:5991-6002.
55. Zhang H., Nguyen-Jackson H., Panopoulos A.D., Li H.S., Murray P.J., Watowich S.S. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 2010, 116:2462-2471.
56. Zhang M., Liu Q., Mi S., Liang X., Zhang Z., Su X., Liu J., Chen Y., Wang M., Zhang Y., et al. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J.Immunol. 2011, 186:4716-4724.
57. Zhou B., Wang S., Mayr C., Bartel D.P., Lodish H.F. miR-150, a microRNA expressed in mature B and Tcells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 2007, 104:7080-7085.